Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926471 · ClinicalTrials.gov registry record · Phase 1
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
A Phase 1 study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00926471: Completed Phase 1 study, sponsored by Virginia Polytechnic Institute and State University.
NCT00926471 is a Phase 1 study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00926471, a Phase 1 study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will develop and test a treatment aimed at reducing anxiety in social situations for children and adolescents with autism spectrum disorders.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT) Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
What the finished NCT00926471 record still lists
NCT00926471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy (CBT) Program is the first listed.
NCT00926471 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00926471 about?
NCT00926471 is a clinical study titled "Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders". This study will develop and test a treatment aimed at reducing anxiety in social situations for children and adolescents with autism spectrum disorders.
What is the current status of trial NCT00926471?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2008-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00926471?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00926471?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00926471's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia